Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Fred M. Schwarzer
AddedMar 31, 2024
UpdatedMay 31, 2026
Fred M. Schwarzer

Fred M. Schwarzer

Co-Founder, Charter Life Sciences

CrunchbaseLinkedIn

Fred M. Schwarzer's Career

Charter Life Sciences
Charter Life Sciences

Santa Clara, CA, US

Co-Founder
IGM Biosciences
IGM Biosciences

Mountain View, CA, US

CEO· C-Suite · Management
Kereos
Kereos

St. Louis, MO, US

Board Member· Board
Minimally Invasive Devices
Minimally Invasive Devices

Columbus, OH, US

Board Member· Board
APT Pharmaceuticals
APT Pharmaceuticals

Burlingame, CA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Fred M. Schwarzer's Career

Charter Life Sciences
Charter Life Sciences
Investment FirmInvestment Firm9Santa Clara, CA, US
Co-Founder

Leadership at Charter Life Sciences

Barr DolanBarr DolanCo-Founder
Don HarrisonDon HarrisonBoard Member

Similar to Charter Life Sciences

Enso VenturesEnso VenturesLondon, Greater London, GBest. 2010Enso VenturesLondon, Greater London, GB · est. 2010

CLS Capital Ltd.: A private firm specializing in equity investments in US & European biomedical sectors.

Investment Firm30
Charter Venture GroupCharter Venture GroupHouston, TX, USCharter Venture GroupHouston, TX, US

Houston-based financial services firm investing in healthcare through private equity and venture capital.

Investment Firm5
CLI VenturesCLI VenturesPalo Alto, CA, USest. 2015CLI VenturesPalo Alto, CA, US · est. 2015

CLI Ventures: A global venture capital firm investing in biotech, healthcare, and tech sectors.

Investment Firm30
LifeSci Venture PartnersLifeSci Venture PartnersNew York City, NY, USest. 2017LifeSci Venture PartnersNew York City, NY, US · est. 2017

LifeSci Venture Partners, formed in 2017, is an early-stage investment firm in life sciences and healthcare.

Investment Firm5
IGM Biosciences
IGM Biosciences
Public$699.3M2582010Mountain View, CA, US
CEO· C-Suite · Management

Leadership at IGM Biosciences

Julie HambletonJulie HambletonBoard Member
Nelson TengNelson TengFounder
William StrohlWilliam StrohlBoard Member
Kereos
Kereos
Series B$27.2M91999St. Louis, MO, US
Board Member· Board

Leadership at Kereos

Gregory LanzaGregory LanzaCo-Founder
Samuel WicklineSamuel WicklineBoard Member
Gary StevensonGary StevensonBoard Member
John RiceJohn RiceBoard Member
Greg JohnsonGreg JohnsonBoard Member
Dr Michael D LobergDr Michael D LobergBoard Member

Similar to Kereos

Keros TherapeuticsKeros TherapeuticsLexington, MA, USBiopharmaceuticalsest. 2015Keros TherapeuticsLexington, MA, US · est. 2015

Keros Therapeutics: A global biotech firm innovating treatments for hematological and musculoskeletal disorders.

Public · $230M105
KerafastKerafastBoston, MA, USReagents, Research Toolsest. 2010KerafastBoston, MA, US · est. 2010

Kerafast, Inc.: A leading reagent firm providing laboratory research tools including cell lines, antibodies, and more.

Angel · $3.9M30
KemiaKemiaSan Diego, CA, USPharmaceuticalsest. 2001KemiaSan Diego, CA, US · est. 2001

Discovering therapeutics for inflammation. Serving US healthcare.

Series C · $100M30
Minimally Invasive Devices
Minimally Invasive Devices
Public$47.1M332009Columbus, OH, US
Board Member· Board

Leadership at Minimally Invasive Devices

Wende HuttonWende HuttonBoard Member
Mike HoovenMike HoovenBoard Member
Jordan S. DavisJordan S. DavisBoard Member
Brent AhrensBrent AhrensBoard Member
Wayne PollWayne PollFounder
Jeff RydinJeff RydinBoard Member

Similar to Minimally Invasive Devices

EndoEvolutionEndoEvolutionRaynham, MA, USMedical Devicesest. 2009EndoEvolutionRaynham, MA, US · est. 2009

EndoEvolution LLC, a US-based medical device company, specializes in automated suturing devices for minimally invasive surgery.

Series C · $8.3M30
SanovasSanovasSan Rafael, CA, USSurgical Toolsest. 2009SanovasSan Rafael, CA, US · est. 2009

Sanovas, Inc. develops and offers minimally invasive surgical tools for complex medical procedures in the US.

Angel · $9.2M39
APT Pharmaceuticals
APT Pharmaceuticals

Burlingame, CA, US

Board Member· Board

Fred M. Schwarzer's Similar Executives & Operators

Nugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakWillix HalimWillix HalimCEO · BukalapakAchmad ZakyAchmad ZakyCo-Founder · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakChi-hyung SongChi-hyung SongBoard Member · DunamuHaeil YiHaeil YiCo-Founder · Dunamu

People Similar to Fred M. Schwarzer

Michael FonsteinMichael FonsteinBoard Member · Quad M SolutionsJessica GrossmanJessica GrossmanBoard Member · Daré BioscienceBruce HironakaBruce HironakaCo-Founder · IgGenixWilliam HearlWilliam HearlBoard Member · BioHealth InnovationKenneth KelleyKenneth KelleyBoard Member · SeromYx SystemsJonathan WangJonathan WangBoard Member · Inmagene Biopharmaceuticals